Women with polycystic ovary syndrome have elevated serum concentrations of and altered GABAA receptor sensitivity to allopregnanolone

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Endocrinology

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/cen.12809PMID 25929428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polycystic ovary syndrome

  2016cited by this paper
• Effects of Roux-en-Y gastric bypass surgery on eating behaviour and allopregnanolone levels in obese women with polycystic ovary syndrome

  2015cited by this paper
• Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome

  2014cited by this paper
• Allopregnanolone induces a diurnally dependent hyperphagic effect and alters feeding latency and duration in male Wistar rats

  2013cited by this paper
• The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

  2009cited by this paper
• An Aging World – demographics and challenges

  2008cited by this paper
• Persistence of tolerance to the anaesthetic effect of allopregnanolone in male rats.

  2008cited by this paper
• Serum levels of 3α-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects

  2007cited by this paper
• Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.

  2007cited by this paper
• High basal serum allopregnanolone levels in overweight girls

  2007cited by this paper
• Polycystic ovary syndrome

  2007cited by this paper
• Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome

  2006cited by this paper
• Pharmacokinetic and behavioral effects of allopregnanolone in healthy women

  2006cited by this paper
• Tolerance development to Morris water maze test impairments induced by acute allopregnanolone.

  2006cited by this paper
• Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder.

  2004cited by this paper
• Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects.

  2003cited by this paper
• Neurosteroid secretion in panic disorder.

  2003cited by this paper
• Increased Response of Plasma Allopregnanolone to Corticotropin-Releasing Hormone in Obese Patients

  2002cited by this paper
• Plasma Levels of Neuroactive Steroids Are Increased in Untreated Women With Anorexia Nervosa or Bulimia Nervosa

  2001cited by this paper
• Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in the male rat.

  2001cited by this paper
• Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women.

  1998cited by this paper
• Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects.

  1998cited by this paper
• Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial.

  1998cited by this paper
• Patients with Premenstrual Syndrome Have a Different Sensitivity to a Neuroactive Steroid during the Menstrual Cycle Compared to Control Subjects

  1998cited by this paper
• Patients with Premenstrual Syndrome Have Reduced Sensitivity to Midazolam Compared to Control Subjects

  1997cited by this paper
• Tolerance to diazepam and changes in GABA(A) receptor subunit expression in rat neocortical areas.

  1997cited by this paper
• Potency of lipid and protein formulation of 5 alpha-pregnanolone at induction of anaesthesia and the corresponding regional brain distribution.

  1995cited by this paper
• Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study.

  1994cited by this paper
• Utility of new procedure for diagnosing mental disorders in primary care

  1994cited by this paper
• Pharmacology of saccadic eye movements in man

  1991cited by this paper
• Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil.

  1991cited by this paper
• Pharmacology of saccadic eye movements in man

  1991cited by this paper
• Reduced benzodiazepine sensitivity in panic disorder.

  1990cited by this paper
• Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma.

  1990cited by this paper
• Radioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma

  1990cited by this paper
• Clinical applications of visual analogue scales: a critical review

  1988cited by this paper
• Benzodiazepine sensitivity in normal human subjects.

  1986cited by this paper
• Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance.

  1984cited by this paper
• Quantitative measurement of saccade amplitude, duration, and velocity

  1975cited by this paper
• Regulation of the human menstrual cycle.

  1974cited by this paper
• Regulation of the human menstrual cycle.

  1971cited by this paper
• Effect of benzodiazepines upon saccadic eye movements in man

  1971cited by this paper
• Access to the Published Version May Require Subscription. Published with Permission From: Pharmacodynamic Properties of Isoallopregnanolone in Healthy Women

  year unknowncited by this paper

• Neuroactive steroid exposure impacts neurodevelopment: Comparison of human and rodent placental contribution

  2025cites this paper
• Neuroactive steroids in the programming of neurodevelopment: implications of maternal obesity

  2025cites this paper
• Polycystic Ovary Syndrome and the Risk of Premenstrual Disorders: A Nationwide Register-Based Study in Sweden

  2025cites this paper
• Neuroendocrine mechanisms responsible for elevated gonadotrophin‐releasing hormone and luteinising hormone pulses in polycystic ovary syndrome

  2025cites this paper
• Unraveling the gut microbiota’s role in PCOS: a new frontier in metabolic health

  2025cites this paper
• Allopregnanolone in the Pathogenesis of the Psychiatric Comorbidities of Polycystic Ovarian Syndrome.

  2025cites this paper
• The impact of GABA and GABAergic pathway in polycystic ovary syndrome: a systematic review

  2025cites this paper
• Metabolic Profiles of Pregnancy With Polycystic Ovary Syndrome: Insights into Maternal-Fetal Metabolic Communication

  2025cites this paper
• Plasma γ-Aminobutyric Acid (GABA) Concentrations in Lactating Holstein Cows during Thermoneutral and Heat Stress Conditions and Their Relationships with Circulating Glucose, Insulin and Progesterone Levels

  2024cites this paper
• Peripartum allopregnanolone blood concentrations and depressive symptoms: a systematic review and individual participant data meta-analysis

  2024cites this paper
• Investigating GABA Neuron–Specific Androgen Receptor Knockout in two Hyperandrogenic Models of PCOS

  2024cites this paper
• Neuroactive steroids in the neuroendocrine control of food intake, metabolism, and reproduction

  2024cites this paper
• Altered GABAA receptor function in women with endometriosis: a possible pain‐related mechanism

  2023cites this paper
• Female sexual behavior is disrupted in a preclinical mouse model of PCOS via an attenuated hypothalamic nitric oxide pathway

  2022cites this paper
• Polycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess.

  2022cites this paper
• Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone

  2021cites this paper
• Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder

  2021cites this paper
• Positive GABAA receptor modulating steroids and their antagonists: Implications for clinical treatments

  2021cites this paper
• Superior mesenteric ganglion neural modulation of ovarian angiogenesis, apoptosis and proliferation by the neuroactive steroid allopregnanolone

  2021cites this paper
• Potential hormonal and neurochemical biomarkers for postpartum depression

  2020cites this paper
• Circulating steroids and mood disorders in patients with polycystic ovary syndrome.

  2020cites this paper
• Allopregnanolone and progesterone in estradiol treated severe postpartum depression and psychosis – Preliminary findings

  2019cites this paper
• Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders

  2019cites this paper
• Neuroendocrine studies in patients with affective disorders

  2019cites this paper
• Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS.

  2018cites this paper
• Dissecting the ontogeny and functional relevance of altered GABAergic circuitry in Polycystic Ovary Syndrome (PCOS)

  2018cites this paper
• GR3027 reversal of neurosteroid-induced, GABA-A receptor-mediated inhibition of human brain function: an allopregnanolone challenge study

  2018cites this paper
• Allopregnanolone alters follicular and luteal dynamics during the estrous cycle

  2018cites this paper
• Puerarin ameliorated the behavioral deficits induced by chronic stress in rats

  2017cites this paper
• The relationship between weight gain during pregnancy and allopregnanolone levels: a longitudinal study

  2017cites this paper
• Allopregnanolone involvement in feeding regulation, overeating and obesity.

  2017influential citation
• Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.

  2016cites this paper
• The author's reply: Blood allopregnanolone levels in women with polycystic ovary syndrome

  2016cites this paper
• The neuroendocrine genesis of polycystic ovary syndrome: A role for arcuate nucleus GABA neurons.

  2016cites this paper
• The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

  2016cites this paper
• Blood allopregnanolone levels in women with polycystic ovary syndrome

  2016cites this paper
• Different transcriptional levels of GABAA receptor subunits in mouse cumulus cells around oocytes at different mature stage

  2016cites this paper